- Home
- PRKS vs APGE Comparison
PRKS vs APGE Comparison
Compare PRKS & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- APGE
- Stock Information
- Founded
- PRKS 1959
- APGE 2022
- Country
- PRKS United States
- APGE United States
- Employees
- PRKS N/A
- APGE N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRKS Health Care
- APGE Health Care
- Exchange
- PRKS Nasdaq
- APGE Nasdaq
- Market Cap
- PRKS 3.2B
- APGE 3.0B
- IPO Year
- PRKS 2013
- APGE 2023
- Fundamental
- Price
- PRKS $55.69
- APGE $47.18
- Analyst Decision
- PRKS Buy
- APGE Strong Buy
- Analyst Count
- PRKS 9
- APGE 5
- Target Price
- PRKS $61.78
- APGE $83.50
- AVG Volume (30 Days)
- PRKS 599.2K
- APGE 571.2K
- Earning Date
- PRKS 11-07-2024
- APGE 11-12-2024
- Dividend Yield
- PRKS N/A
- APGE N/A
- EPS Growth
- PRKS 2.23
- APGE N/A
- EPS
- PRKS 3.84
- APGE N/A
- Revenue
- PRKS $1,729,882,000.00
- APGE N/A
- Revenue This Year
- PRKS $1.59
- APGE N/A
- Revenue Next Year
- PRKS $1.25
- APGE N/A
- P/E Ratio
- PRKS $14.18
- APGE N/A
- Revenue Growth
- PRKS 0.10
- APGE N/A
- 52 Week Low
- PRKS $44.72
- APGE $27.05
- 52 Week High
- PRKS $60.83
- APGE $72.29
- Technical
- Relative Strength Index (RSI)
- PRKS 48.24
- APGE 48.09
- Support Level
- PRKS $52.56
- APGE $46.12
- Resistance Level
- PRKS $58.41
- APGE $48.42
- Average True Range (ATR)
- PRKS 1.76
- APGE 3.19
- MACD
- PRKS -0.40
- APGE 0.30
- Stochastic Oscillator
- PRKS 39.47
- APGE 55.87
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc operates in the United States leisure industry. Its core business is the operation of theme parks and such entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove and Sesame Place. The company generates majority of its revenue from selling admission tickets for its theme parks.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.